CoChat

CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer

Open access

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Regulatory T cells (Tregs) are often enriched in tumors, where their immunosuppressive function has a key role in tumor persistence and progression. In colorectal cancer (CRC), however, Tregs are frequently associated with an improved clinical outcome. Tumor-infiltrating Tregs have been shown to exhibit a distinct signature comprising the co-stimulatory molecules (OX40, 4-1BB), cytokine receptors (IL1R2, IL21R, CCR8, CD30), and co-inhibitory molecules (PD-L1, TIGIT). Here, we showed by flow cytometry that circulating CD45RO+Tregs from patients with CRC (n = 25) have elevated CD30 and OX40 expression compared to healthy subjects (n = 14). We identified co-expression of CD30 and OX40 on circulating CD45RO+Tregs using single-cell images captured by the DEPArray™system. The frequency of CD30+OX40+CD45RO+Tregs was significantly higher in CRC patients than in healthy subjects (P < 0.001). Importantly, receiver operating characteristic analysis confirmed that this CD30+OX40+Treg subset could strongly discriminate between CRC patients and healthy subjects with the highest accuracy of 92.3%, an AUC of 0.92, a sensitivity of 88%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 82.35%, and a trade-off value of 3.44%, compared to other Treg subsets. Consistently, multiplex-IHC/IF of tumor-infiltrating Tregs revealed a significant association between high densities of CD30+OX40+Tregs and improved overall survival; no such association was found for other subsets. These data suggest a potential role for CD30+OX40+Tregs as a diagnostic or prognostic biomarker in CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00262-021-02859-x

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Tumor-infiltrating Tregs in CRC were predominantly CD45RO+ and expressed co-stimulatory molecules and cytokine receptors at varying levels. a Gating strategy for the analysis of Tregs by FCM. Data from four healthy subjects are presented as an example. CD4+ T cells were negatively selected from PBMCs using magnetic beads. Tregs were defined as CD4+CD25+CD127– cells; Foxp3 expression was significantly higher than Tconvs. MFI: geometric mean fluorescence intensity. Statistical analysis was performed using the two-tailed paired t test. *** denotes P < 0.001. b Phenotype of tumor-infiltrating Tregs. Tumor specimens from five CRC patients were dissociated into single-cell suspensions for analysis. Representative plots are shown. Numbers within plots represent percentages. Gates for dot plots were drawn based on isotype control antibodies. Dotted histogram: isotype control antibody; filled histogram: antigen-specific antibody. c Proportions of CD45RO+ tumor-infiltrating Tregs expressing individual protein markers
Fig. 1 Tumor-infiltrating Tregs in CRC were predominantly CD45RO+ and expressed co-stimulatory molecules and cytokine receptors at varying levels. a Gating strategy for the analysis of Tregs by FCM. Data from four healthy subjects are presented as an example. CD4+ T cells were negatively selected from PBMCs using magnetic beads. Tregs were defined as CD4+CD25+CD127– cells; Foxp3 expression was significantly higher than Tconvs. MFI: geometric mean fluorescence intensity. Statistical analysis was performed using the two-tailed paired t test. *** denotes P < 0.001. b Phenotype of tumor-infiltrating Tregs. Tumor specimens from five CRC patients were dissociated into single-cell suspensions for analysis. Representative plots are shown. Numbers within plots represent percentages. Gates for dot plots were drawn based on isotype control antibodies. Dotted histogram: isotype control antibody; filled histogram: antigen-specific antibody. c Proportions of CD45RO+ tumor-infiltrating Tregs expressing individual protein markersCC BY · PubMed Central
Fig. 2 Increased expression of CD30 and OX40 by circulating CD45RO+ Tregs from CRC patients. a Representative dot plots and histograms of CD30 and OX40 expression on CD45RA−CD45RO+ Tregs from healthy subjects (n = 14) and CRC patients (n = 25) are shown. Numbers within plots represent percentages. Gates for dot plots were drawn based on isotype control antibodies. White-filled histogram: isotype control antibody; gray-filled histogram: antigen-specific antibody. b, d Proportions of circulating OX40+ Tregs and corresponding MFI in healthy subjects and CRC patients. c, e Proportions of circulating CD30+ Tregs and corresponding MFI in healthy subjects and CRC patients. f Proportions of circulating CD4+CD25+CD127− Tregs in healthy subjects and CRC patients. Means ± SD are shown. Statistical analyses in b–f were performed using the two-tailed unpaired t test with Welch’s correction. *, **, and **** denote P < 0.05, P < 0.01, and P < 0.0001, respectively
Fig. 2 Increased expression of CD30 and OX40 by circulating CD45RO+ Tregs from CRC patients. a Representative dot plots and histograms of CD30 and OX40 expression on CD45RA−CD45RO+ Tregs from healthy subjects (n = 14) and CRC patients (n = 25) are shown. Numbers within plots represent percentages. Gates for dot plots were drawn based on isotype control antibodies. White-filled histogram: isotype control antibody; gray-filled histogram: antigen-specific antibody. b, d Proportions of circulating OX40+ Tregs and corresponding MFI in healthy subjects and CRC patients. c, e Proportions of circulating CD30+ Tregs and corresponding MFI in healthy subjects and CRC patients. f Proportions of circulating CD4+CD25+CD127− Tregs in healthy subjects and CRC patients. Means ± SD are shown. Statistical analyses in b–f were performed using the two-tailed unpaired t test with Welch’s correction. *, **, and **** denote P < 0.05, P < 0.01, and P < 0.0001, respectivelyCC BY · PubMed Central
Fig. 3 CRC is associated with an increase in circulating CD45RO+CD30+OX40+ Tregs. a Representative dot plots showing co-expression of CD30 and OX40 by CD45RO+ Tregs. Gates were drawn based on isotype control antibodies. b Treg cells imaged by the DEPArray™ NxT digital sorting system. Each row represents a single cell imaged in brightfield and four fluorescent channels. c–e Comparison of frequencies of circulating CD30+OX40+, CD30–OX40+, or CD30+OX40−CD45RO+ Tregs between healthy subjects (n = 14) and CRC patients (n = 25). Means ± SD are shown. Statistical analysis was performed using the two-tailed unpaired t test with Welch’s correction. *** denotes P < 0.001. f ROC analysis of % circulating CD45RO+CD30+OX40+ Tregs in discriminating healthy subjects and CRC patients, with AUC = 0.92, sensitivity = 88%, specificity = 100%, positive predictive value = 100%, negative predictive value = 82.35%, accuracy = 92.3% at a trade-off value of 3.44%. g ROC analysis of % circulating CD45RO+CD30−OX40+ Tregs in discriminating healthy subjects and CRC patients, with AUC = 0.90, sensitivity = 85.7%, specificity = 92%, positive predictive value = 92%, negative predictive value = 85.7%, accuracy = 89.7% at a trade-off value of 3.37%. h ROC analysis of % circulating CD45RO+OX40+ Tregs in discriminating healthy subjects and CRC patients, with AUC = 0.91, sensitivity = 84%, specificity = 78%, positive predictive value = 87.5%, negative predictive value = 73.3%, accuracy = 82% at a trade-off value of 8.87%
Fig. 3 CRC is associated with an increase in circulating CD45RO+CD30+OX40+ Tregs. a Representative dot plots showing co-expression of CD30 and OX40 by CD45RO+ Tregs. Gates were drawn based on isotype control antibodies. b Treg cells imaged by the DEPArray™ NxT digital sorting system. Each row represents a single cell imaged in brightfield and four fluorescent channels. c–e Comparison of frequencies of circulating CD30+OX40+, CD30–OX40+, or CD30+OX40−CD45RO+ Tregs between healthy subjects (n = 14) and CRC patients (n = 25). Means ± SD are shown. Statistical analysis was performed using the two-tailed unpaired t test with Welch’s correction. *** denotes P < 0.001. f ROC analysis of % circulating CD45RO+CD30+OX40+ Tregs in discriminating healthy subjects and CRC patients, with AUC = 0.92, sensitivity = 88%, specificity = 100%, positive predictive value = 100%, negative predictive value = 82.35%, accuracy = 92.3% at a trade-off value of 3.44%. g ROC analysis of % circulating CD45RO+CD30−OX40+ Tregs in discriminating healthy subjects and CRC patients, with AUC = 0.90, sensitivity = 85.7%, specificity = 92%, positive predictive value = 92%, negative predictive value = 85.7%, accuracy = 89.7% at a trade-off value of 3.37%. h ROC analysis of % circulating CD45RO+OX40+ Tregs in discriminating healthy subjects and CRC patients, with AUC = 0.91, sensitivity = 84%, specificity = 78%, positive predictive value = 87.5%, negative predictive value = 73.3%, accuracy = 82% at a trade-off value of 8.87%CC BY · PubMed Central
Fig. 4 A high density of tumor-infiltrating CD30+OX40+ Tregs is associated with improved OS after surgery. a–e Multiplex-IHC/IF of representative tumor section at 200X magnification. Color scheme is as follows: CD30 (green), OX40 (red), Foxp3 (white), and DAPI (blue). Single staining for CD30 (a), OX40 (b), Foxp3 (c), DAPI (d), and triple-staining for CD30, OX40, and Foxp3 (e) are shown. White arrow: CD30+OX40+ Treg cell; T: tumor island. f–k Kaplan–Meier curves of OS and DFS of CRC patients who underwent surgery. Patients were segregated into high (green curve) and low (red curve) groups based on the density of different tumor-infiltrating Tregs: f, i CD30+OX40+ Tregs, g, j CD30–OX40+ Tregs, h, k CD30+OX40− Tregs. Survival outcomes were compared between groups using univariate analysis. P value is indicated in each graph
Fig. 4 A high density of tumor-infiltrating CD30+OX40+ Tregs is associated with improved OS after surgery. a–e Multiplex-IHC/IF of representative tumor section at 200X magnification. Color scheme is as follows: CD30 (green), OX40 (red), Foxp3 (white), and DAPI (blue). Single staining for CD30 (a), OX40 (b), Foxp3 (c), DAPI (d), and triple-staining for CD30, OX40, and Foxp3 (e) are shown. White arrow: CD30+OX40+ Treg cell; T: tumor island. f–k Kaplan–Meier curves of OS and DFS of CRC patients who underwent surgery. Patients were segregated into high (green curve) and low (red curve) groups based on the density of different tumor-infiltrating Tregs: f, i CD30+OX40+ Tregs, g, j CD30–OX40+ Tregs, h, k CD30+OX40− Tregs. Survival outcomes were compared between groups using univariate analysis. P value is indicated in each graphCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 1

  1. Garnelo M, Tan A, Her Z, Yeong J, Lim CJ, Chen J, Lim KH, Weber A, Chow P, Chung A, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Chen Q, Abastado JP, Chew V (2015) Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut 15(310814):2015–310814

Cited by

See all 32

Metadata

Authors
Lam, J. H., Hong, M., Koo, S.-L., Chua, C. W. L., Lim, K. L., Wee, F., Wan, W. K., Leow, W. Q., Yeo, J. G., Tan, I. B. H., Yeong, J., Lim, T. K. H., & Lim, T. S.
Affiliations
  • National Cancer Centre Singapore (SG)
  • Singapore General Hospital (SG)
  • SingHealth Duke-NUS Academic Medical Centre (SG)
  • Agency for Science, Technology and Research (SG)
  • SingHealth (SG)
Corresponding author
  • Yeong, Joe
  • Lim, Tony Kiat Hon
  • Lim, Tong Seng
Venue
Cancer Immunology, Immunotherapy
Published
2021-02-02
Volume
70
Issue
8
Pages
2353-2365
ISSN
  • 0340-7004 (ISSN-L)
  • 1432-0851
OpenAlex
W3129005829
Cited by
31
References
68
Citations by year
2026: 4 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 6
FWCI
1.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Cancer Immunology Immunotherapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Singapore General Hospital
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
colorectal cancer, regulatory T cells, CD30, OX40, CD45RO, tumor-infiltrating Treg cells, prognostic factors, overall survival, tumor immunosuppression, diagnostic biomarkers, tumor-infiltrating immune cells
MeSH terms
Cells, Cultured, Humans, Prospective Studies, Retrospective Studies, Biomarkers, Tumor, Colorectal Neoplasms, Leukocyte Common Antigens, Ki-1 Antigen, Receptors, Cytokine, T-Lymphocytes, Regulatory, Receptors, OX40

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer. https://app.cochat.ai/papers/10.1007/s00262-021-02859-x
The paper
Lam, J. H., Hong, M., Koo, S.-L., Chua, C. W. L., Lim, K. L., Wee, F., Wan, W. K., Leow, W. Q., Yeo, J. G., Tan, I. B. H., Yeong, J., Lim, T. K. H., & Lim, T. S. (2021). CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-021-02859-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.